The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Share News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Falanx loss widens but orders return to pre-pandemic level

Wed, 29th Sep 2021 13:07

Falanx Group Ltd - AIM-listed provider of cyber security and strategic intelligence services - Pretax loss in the financial year that ended March 31 widens to GBP3.6 million from GBP2.9 million the year before. Revenue slips to GBP5.2 million from GBP5.9 million. Notes monthly recurring revenues broadly consistent with 2020. Says order intake now ahead of pre-Covid-19 pandemic levels.

Chief Executive Mike Read says: "Cyber protection is no longer a 'nice to have', instead it is an essential part of any business risk discussion. Hackers and criminals are attacking every sector and every size of organisation. With the need for home working, arising from Covid-19, hacking has been made easier and risks have increased, organisations can no longer avoid investing in protecting themselves.

"Clearly like other organisations we have experienced some delays in the progress of our business due to Covid-19 but recent growth has been encouraging and it seems as though these are now behind us."

Looking ahead, Read says company "well positioned" to take advantage of "increasingly favourable cyber-security market trends" to "deliver significant shareholder value".

Current stock price: 1.00 pence, down 4.8% on Wednesday

Year-to-date change: down 7.4%

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.